# DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
> **ANDA217000** · Abbreviated New Drug Application (Generic) · Sponsor: BIONPHARMA · Approved 2023-08-04
## Drug
- **FDA Application Number:** ANDA217000
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
- **Generic name:** DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
- **Active ingredients:** DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BIONPHARMA
- **Manufacturer:** Bionpharma Inc.,
- **First approval:** 2023-08-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217000)
---
*MORVS · CC0 1.0*